chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The process of breathing is painful, which includes her arms hurting and it hurts to breathe when she takes more than a shallow breath, after the first vaccine; The process of breathing is painful, which includes her arms hurting and it hurts to breathe when she takes more than a shallow breath, after the first vaccine; Difficult to sleep, as breathing is painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03May2021 10:00 (Batch/Lot number: unknown) at the age of 27 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAINFUL RESPIRATION (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 03May2021, outcome "not recovered" and all described as "The process of breathing is painful, which includes her arms hurting and it hurts to breathe when she takes more than a shallow breath, after the first vaccine"; INSOMNIA (non-serious) with onset 03May2021, outcome "not recovered", described as "Difficult to sleep, as breathing is painful". Additional information: The patient reconfirmed that she was calling about the Pfizer Covid 19 vaccine, got her vaccine yesterday. The patient was calling to report her symptoms, because her parents were concerned for her, and they wanted her to make this call. when patient takes a deep breath, or more than a shallow breath, her arms hurt a lot and it hurts to breathe. Patient reclarified that her lungs and chest do not hurt, but it was the entire process of breathing that was painful. Caller reclarified that it was the process of breathing was painful, which includes her arms hurting and it hurts to breathe when she takes more than a shallow breath. Difficult to sleep, as breathing was painful at night. The patient stated that the number was handwritten, and she thinks the letters were EW or they could be BN, followed by the numbers 0170. No History of all previous immunization with the Pfizer vaccine considered as suspect. No additional Vaccines Administered on Same Date of the Pfizer Suspect. Events did not require a visit to emergency room or physician office. No prior vaccinations (within 4 weeks). No events following prior vaccinations. No patient medical history (including any illness at time of vaccination). No relevant tests.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Lot of problems after second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Lot of problems after second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Lot of problems after second dose). At the time of the report, VACCINATION COMPLICATION (Lot of problems after second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information was provided.  Treatment information was not provided.  Reporter thought not getting second dose because reporter concerned about it being unapproved and heard a lot of things about the second dose
severe thrombocytopenia approx 3wk p/vax;plt count 1-2k on 27MAY96;did not respond to IVIG therapy in hosp-presently under care of hematologist
Patient experienced face swelling/redness, throat swelling, and difficulty breathing ~5 hours after receiving Afluria influenza vaccine. Patient then self-treated with oral antihistamine (Benadryl) and was stabilized with no further worsening of symptoms during the night. Patient called the following day to pharmacy to report event to pharmacist and was without further complication from the reaction.
At the time of the injection, it felt like there was a knife being inserted in my arm.  The pain was overwhelming.  The pain has been consistent, the swelling has not gone down around the injection site.  Around the injection site is very warm to the touch.  It feels like the injection hit the joint in my upper left arm.
Pt had a swollen arm all the way up from the bicep and also the tricep and red, pt went to MD who gave antibiotics.
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to a 11-year-old male patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 02-FEB-2023, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.
tested positive for Covid-19; Covid-19; This is a spontaneous report from a contactable consumer. A 24-year-old male patient received bnt162b2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EP6955), dose 1 intramuscular, administered in left arm on 26Mar2021 09:00 (at age of 24-year-old) as dose 1, single and then second dose of bnt162b2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EP6955), intramuscular, administered in left arm on 17Apr2021 10:30 (at age of 24-year-old) as dose 2, single for covid-19 immunization at clinic. The patient medical history was not reported. Concomitant medications included Vita Fusion multivitamin gummies within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. Patient TL tested positive for Covid-19 on Saturday 16Oct2021 at 08:30 AM (PCR test via nasal swab administered on Friday 15Oct2021). Patient was experiencing minor fever, cough, and nasal congestion. Patient had no known exposure prior to testing positive. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal swab): positive on 15Oct2021. The outcome of event covid-19 was recovering.  No follow-up attempts are possible. No further information is expected.
First Moderna Vaccine shot on 3/4/2021- Sore Arm dizziness but only lasted about a day.  Second Moderna Vaccine shot on 4/1/2021- Sore Arm dizziness Fever. The dizziness and fever went away after a day sore are lasted about 5 days.  After that was normal until about 2 1/2 weeks after the shot on 4/20/2021 I went to the hospital due to extreme dizziness,  ears hurt along with eye pressure.   At the hospital they tried to clean out my ears due to some wax which made me even more dizzy which they shot lorazepam into my arm to calm me down.  The was the same arm that got the covid vaccine in it so I wondering if that had any effect on my condition also?  They gave me meclizine to take as needed and told me I should go to an ENT to get checked further.    The doctor then took the wax out with a tool but bruised my ear drum due to this and gave me ofloxacin to clean the blood and said it would heal soon.  Nothing got better so I figured maybe I had some depression and anxiety due to this covid crisis and saw a therapist who prescribed me buspirone which did nothing but give me headaches and hydroxyzine after that to try and see if that was better. Both medicines did nothing and I stopped taking both after about a week.   I ended up going to the hospital two more times on 4/26/2021 and June 20/2021 and they just gave me amoxiciilin in June and said to see the ENT again  I went to the ENT once in April and again in June and asked about ear wax and dizziness. He said you don't have vertigo and that my ear drum was healed in the June visit
Extreme weakness; gastro issues; she had a low grade fever; This is a spontaneous report from a contactable consumer. This consumer reported for a 73-year-old female patient received first dose of bnt162b2 (COVID 19, Pfizer), via unknown route of administration on Jan2021 at single dose for covid-19 immunisation. Medicla history was unknown. No Known allergies. Concomitant medications included other vaccine in 4 weeks product for Shingles. Facility type vaccine was other. The patient experienced Extreme weakness and gastro issues from Jan2021. She had a low grade fever (100 degrees) from Jan2021. Yesterday she mentioned she is feeling better than the initial reaction but not yet 100%. The outcome of the event was recovering. No treatment received. No COVID prior vaccination. No COVID tested post vaccination.   Information about Lot/Batch number is requested.
Pt had first vaccine and four hours later felt her throat was "closing" off.  She did not need any treatment and it resolved.  Right after that, a fever of 101 started and lasted 5-7 weeks.  The first day she also had a sensation of painful skin all over that lasted one day.  SHe had arthralgias and myalgias that lasted a week.  A week after vaccine her right grip became weak and she felt n/t at times in her limbs and difficulty knowing where her feet were at times and coordination was off.  This resolved almost completely before second immunization.  When having second immunization, within a couple of hours later her symptoms of joint pain, muscle pain, lack of coordination and weakness and weakened grips worsened.  THis has continued.
SORE ARM; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm. This report was non-serious.
Site: Swelling at Injection Site-Mild, Systemic: Lymph Node Swelling-Mild, Additional Details: lymph node swelling
1145 started w/fever and raspy voice (102.6 R)* sleepy 1700 temperature 103.6 degrees R* tired & washed out pale 1830 to ER  *alternated TYLENOL and MOTRIN without relieve.
pt recv vax 3AUG95 & 11DEC97 pt devel a rash that consisted of little red blisters all over face, trunk, arms, & legs;
Patient said he started to feel light headed, then tingling in all extremities, also had a sense of panic/anxiety - he said "it came in waves"  His ears and neck were flushed - he complained of a dry mouth  He said we felt hot and cold   He had no shortness of breath or chest heaviness, his O2 sats remained at 97-98%  10:25 AM   BP 179/105 Pulse 90   O2 sat 98% 10:35 AM   BP 169/102  Pulse 94   O2 sat 97%   10:45 AM   BP 180/104  Pulse 84   O2 sat 97%  Clinic is attached so the provider did come to see Patient  Observed until 11:15 AM - his wife arrived to give him a ride home  Provided a BP monitor and pulse oximeter to monitor at home -  Planned to take OTC benadryl at home   To follow up with provider at clinic to review reaction  Called Patient at home at 2:45 PM and says he is feeling better but very tired - Has taken benadryl twice
Hospitalization due to COVID-19 infection. Presented to ER with complaints of back pain and coughing. Admitted to hospital for back pain, pleuritic pain, and COVID-19 pneumonia. Treated with 2 L oxygen via NC, remdesivir, decadron, and antibiotics
Severe chills and contracting chest pains that was intermittent , probably around at midnight and I work up in pain, Called my cardiologist and he just go the ER. was there for 6 hours. Follow up with specialist and took a while to go away.
134 pm,  c/o not feeling well, feeling faint 116/78,  laid down, weak and dizzy. Reports history of lupus, and possible mass cell activation syndrome. Allergic to bactrim, black pepper, nutmeg- carries epi pen.  C/o tightening in throat, red in face, but no shortness of breath, some occasional coughing. 1:36 tingling of R arm where vaccine was given. 128 pm b/p 118/86, 98%, 86 HR, coughing some, and tingling of face, hands, and arm. 1:48 pm b/p 116/78, 95% O2, 81 HR, still some coughing, SOB, shaking- face not as red. R arm, hand, and face numb. 1:46 Attempt to call MD. Tried water, c/o dizziness. 1:51 pm Resp. more labored- coughing more. 1:52 benadryl 50mg, in L arm. 1:54pm breathing slowed down, pulse ox 100%, says throat starting to feel better. 158 pm 102/70 b/p,  98% O2, 78 HR, 20 RR, Both hands, arms, and face numb. 208 pm- 98% O2, says throat is feeling better. 2:15- sitting- feeling a little dizzy. After 5-10 minutes she felt good enough to leave. Instructed to call 911 if anything returned or worsened.
per mom generalized rash following vax 13OCT93; presents 17DEC93 w/above hx & large patches of hypopigmentation of face & chest w/fine macularpapular lesions on arms;
Red spot around injection site that showed up 2 days after the injection. Roughly a week after the injection, I noticed a hard lump where I got my injection that is roughly 1.5 inches in diameter. It is red and it is slightly itchy but is not causing any pain. It is a bit raised on my skin.
Itching; Chills; Redness at injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE PRURITUS (Itching) and PAIN IN EXTREMITY (Sore arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012NM20A) for COVID-19 vaccination.     The patient's past medical history included Arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Arthritis.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced CHILLS (Chills), VACCINATION SITE ERYTHEMA (Redness at injection site) and PAIN IN EXTREMITY (Sore arm). On 04-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching). The patient was treated with ALCOHOL at an unspecified dose and frequency. On 03-Mar-2021, CHILLS (Chills) and PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PRURITUS (Itching) had not resolved.            Treatment information include application of alcohol pad topically on the affected area Action taken with mRNA-1273 in response to the drug was not applicable.   Reporter did not allow further contact
felt flu like; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program.  A 18 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) at the age of 18 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Ankylosing spondylitis" (ongoing). Concomitant medication(s) included: ENBREL taken for ankylosing spondylitis. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 2021, outcome "recovered" (2021), described as "felt flu like".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Immediately tasted metal in my mouth, after waiting 15 mintues I felt intoxicated but drove home, within 24 hours my lymph gland under my arm swelled to a size of a golf ball,within 7 days I went to regular doctor with heart pain and palputations, lower back pain, confusion and brain fog.  He referred me to a cardiologist and within a week I was admitted to the Hospital.  12/24/2021 experienced heart palpatations, confusion, cold hands and feet, sweat and nausia and d 12/26/2021  went to Emegency Center with the same symptoms.   Have had 6 episodes of heart palpatations, confusion, cold hands and feet, sweat, eye twitching, ears ringing, nausea and depersonalisation.
No additional AE reported; a 2 month old infant was inadvertently administered a dose of PROQUAD; This spontaneous report was received from a physician, referring to a 2 months old patient. The patient's medical history and concurrent condition were not provided. Concomitant medication included sterile diluent.      On 26-MAY-2022, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # U031563, expiration date 06-APR-2023; strength, dose number and route were not reported) at dose of 0.5 milliliter for prophylaxis (product administered to patient of inappropriate age). No additional adverse event (AE) reported.
fever that lasted for a day then it resolved; This is a spontaneous report from a Pfizer sponsored program IBCC (Inbound Call Center for HCPs). A non-contactable consumer reported for a male patient (her husband). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced fever that lasted for a day then it resolved on an unspecified date with outcome of recovered on an unspecified date. Caller wanted to know any data available for covid vaccine use in GBS (Guillain-Barre syndrome) and autoimmune disorder. caller sated her husband had reaction to the vaccine, fever that lasted for a day then it resolved. caller stated she has autoimmune disease also so wanted to know does the vaccine worsen the symptoms.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
The day after vaccination (Day 2) she had stiffness in both upper arms and upper legs. On day 3,  she had body pain. That same night she experienced extreme muscle weakness, headache, chills, night sweats, nausea,  temporary loss of hearing in her right ear, and didn't want to eat or drink anything. These symptoms continued for a week.
Patient presented due to a motor vehicle crash but has been experiencing COVID symptoms and was positive. Patient is fully vaccinated  but not boosted.
Child presented with foster mom on December 23, 2014 for shots.  Child was behind on vaccines.  The nurse adminstering vaccines had intended to adminster Pediarix, Hep A, Varicella, and Hib. However, in error the child received Pediarix, Pentacel, Hep A and Varicella. Contact was made with primary care provider and child's guardian.  Spoke with guardian this AM (8:00; denies any signs of adverse reaction.
Fever for two days following booster, with headache, chills, and muscle pain from shot location.   Swollen shoulder, hot and hard to touch contiuing on day three, discomfort from shoulder to fingertips of right arm, slightly swollen hand compared to left hand, unable lift arm higher than parallel with shoulder.
Ran a temperature, low grade. Sore and tender on arm and under armpit. Oblong rash. Hot to touch. Right arm only. Felt fatigue following the next day.
Patient stated to me that he was fine when he woke up the next morning after the injection, then mid morning his face started feeling weird and tingling and his son called the ambulance. The next thing he knew he was in the Hospital. Not sure what all happened while in the hospital but patient sates he was there over a week and he still had a trach in when he came by pharmacy.
No additional AE reported.; Caller reported that a patient received the dose of RECOMBIVAX HB twice. Patient received the scheduled dose at 8 weeks on 8/31/2022 and received an additional dose at 17 weeks on 10/31/2022.; This spontaneous report has been received from a nurse referring to a 3-month-old male patient. The patient's medical history, previous drug reactions or allergies, and concomitant therapies were not reported.  On 31-AUG-2022, the patient was vaccinated with an scheduled dose at 8 weeks of hepatitis b vaccine (recombinant) (thimerosal free) (RECOMBIVAX HB) intramuscular injection, and it was reported that he received an additional dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) at 17 weeks on 31-OCT-2022, both administrations at a dose of 0.5 milliliter (ml) (strength, vaccination scheme frequency, route of administration, and anatomical site of application were not provided; lot number W022795 that was verified to be valid, expiration date not reported, but upon internal validation established as 19-MAY-2025) as prophylaxis (inappropriate schedule of product administration).  There was no additional adverse event (AE) reported (no adverse event).
This case was reported by a nurse to a sales representative and described the occurrence of an injection site reaction in an adult male pt who received hepatitis A inactivated & hepatitis B recombinant vaccine (Twinrix). On an unspecified date in 10/04, the pt received the 1st dose of Twinrix. At an unspecified time following the 1st administration of Twinrix, on the same day in 10/04, the pt experienced a "knot" at the injection site. The outcome of the event was not reported. The nurse considered the injection site reaction to possibly be related to vaccination with Twinrix.
This case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 62-year-old female patient who received ENGERIX B adult (batch number UNKNOWN, expiry date unknown). Co-suspect products included TWINRIX adult. Previously administered products included TWINRIX adult (dose 1). On 11th June 2014, the patient received the 2nd doses of ENGERIX B adult. On an unknown date, the dose was an unknown dose. On an unknown date, the patient experienced wrong vaccine administered and underdose. On an unknown date, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the wrong vaccine administered, underdose and drug dose administration interval too long were unknown. Additional information: 62 yo female (received TWN 1st dose on 3-28-2014 from a store and then went to another PY and received only the adult 20 mcg ENG-B monovalent vaccine on 6-11-2014. Now she is showing up at this store PY for third dose, which is also delayed just as the 2nd dose was Maladministration.